Dr Reddys Laboratories Share Price Today - Live Blog for April 07, 2025

The share price of Dr Reddys Laboratories Ltd soared by an impressive 0.42%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,091.40 per share.

The stock of Dr Reddys Laboratories Ltd is making significant strides, boasting a 0.30% increase and currently trading at ₹1,092.00 per share. This upward trajectory is turning heads in the market.

The share price of Dr Reddys Laboratories Ltd experienced a -0.52% slump and is currently trading at ₹1,087.85. While the stock maintains a PE ratio of 17.2400, the industry PE is 33.0184, raising questions about valuation.

After a significant 0.07% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,093.50 in the current market. This upward movement is attracting attention from both retail and institutional investors.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.04% drop, and it's now trading at ₹1,092.35 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Dr Reddys Laboratories Ltd experienced a substantial 0.08% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,094.00, making it an appealing option for investors.

Dr Reddys Laboratories Ltd's shares saw an increase of 0.06%, reaching the current market price of ₹1,090.80. This development underscores the stock's growing popularity.

Dr Reddys Laboratories Ltd's stock price surged by 0.06%, reaching the current market value of ₹1,090.80 per share. This surge is a testament to the stock's recent performance.

The share price of Dr Reddys Laboratories Ltd experienced a -0.15% slump and is currently trading at ₹1,091.45. While the stock maintains a PE ratio of 17.2400, the industry PE is 33.0184, raising questions about valuation.

The stock of Dr Reddys Laboratories Ltd suffered a -0.03% decline, and it currently trades at ₹1,093.10 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

With a remarkable 0.45% increase in value, the share price of Dr Reddys Laboratories Ltd currently stands at ₹1,093.90. Notably, this stock has a Price-to-Earnings (PE) ratio of 17.2400, while the industry's PE ratio is 33.0184.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.26% drop, and it's now trading at ₹1,086.20 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

The share price of Dr Reddys Laboratories Ltd plunged by -0.26%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,086.20, but investors are assessing whether this is a temporary dip or a long-term trend.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.26% drop, and it's now trading at ₹1,086.20 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Dr Reddys Laboratories Ltd experienced a -0.04% dip in its share price and is currently trading at ₹1,095.85. The stock has a PE ratio of 17.2400, an ROE of 17.3623% and a debt to equity ratio of 0.1579.

After a notable 0.38% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,096.00. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1579 and an ROE of 17.3623%.

Dr Reddys Laboratories Ltd experienced a -0.04% downturn in its share price, and it's currently trading at ₹1,091.90. This situation is generating interest among value investors who are evaluating the stock's potential.

Dr Reddys Laboratories Ltd's share price rallied by 0.41%, reaching the current market price of ₹1,093.90. This surge is indicative of the stock's recent positive performance.

Dr Reddys Laboratories Ltd's stock price surged by 0.88%, reaching the current market value of ₹1,090.55 per share. This surge is a testament to the stock's recent performance.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 0.25%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,080.50 per share.

Dr Reddys Laboratories Ltd experienced a substantial 0.02% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,076.15, making it an appealing option for investors.

Dr Reddys Laboratories Ltd's share price has fallen by -0.11%, a situation worth noting. At present, the stock is trading at ₹1,076.45. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 17.2400, while the industry PE ratio is 33.0184.

Dr Reddys Laboratories Ltd experienced a -1.03% dip in its share price and is currently trading at ₹1,078.40. The stock has a PE ratio of 17.2400, an ROE of 17.3623% and a debt to equity ratio of 0.1579.

Dr Reddys Laboratories Ltd witnessed a notable 0.90% surge in its share price and is presently trading at ₹1,089.45, captivating the attention of market participants.

Following a noteworthy 5.49% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,082.20. When it comes to valuation, this stock has a PE ratio of 17.2400, with the industry PE ratio at 33.0184.